By Marilyn T.  McGoldrick, Esq. Published on May 28, 2019 A Philadelphia jury ordered Ethicon, a subsidiary of Johnson and Johnson, to pay $80 million dollars to a woman who was injured by her Prolift transvaginal mesh implant. The verdict included an award of $50 million dollars in punitive damages. This is the 10th mesh-related… Read More


Transvaginal Mesh Sales Halted The U.S. Food and Drug Administration (FDA) has ordered makers of transvaginal surgical mesh implants to immediately stop the distribution and sale of the products in the United States. The FDA said that Boston Scientific and Coloplast, the last two companies selling these products in the U.S., have not demonstrated “a… Read More


Johnson & Johnson’s Ethicon subsidiary was ordered to pay plaintiff Ella Ebaugh $57 million dollars for injuries she suffered from their transvaginal mesh implants. The verdict, rendered in Philadelphia Common Pleas Court, was the largest verdict in the Philadelphia  mass tort litigation. … Read More


A Pennsylvania state court jury awarded $2.16 million in damages to a woman with an Ethicon ProLift +M Pelvic Floor Repair System which eroded inside her body and cannot be removed. This is the fourth consecutive win for plaintiffs in the Philadelphia Court of Common Pleas, and the fourth multi-million dollar award against Johnson & Johnson and its subsidiary Ethicon. It is the first time punitive damages were not awarded.… Read More


A jury has returned a verdict of $20,000,000 for a New Jersey woman who has been in constant pain since receiving a vaginal mesh implant made by Johnson & Johnson’s Ethicon unit. The jury awarded $2.5 million in compensatory damages for pain, suffering, and economic loss, and $17.5 million in punitive damages to punish J&J and Ethicon for failing to warn about the risks of mesh implants.… Read More


A Philadelphia jury has awarded $13.5 million to Sharon Carolino who claimed permanent damages from an Ethicon TVT midurethral sling mesh implant. This was the second verdict against Johnson & Johnson’s Ethicon unit in a pelvic mesh case. In December a jury awarded $12.5 million against J&J for injuries caused by another mesh product, the Ethicon ProLift pelvic organ prolapse repair kit.… Read More


A new lawsuit accuses transvaginal mesh manufacturer Boston Scientific of smuggling counterfeit pelvic mesh from China. Boston Scientific is charged with intentionally defrauding and endangering women by secretly importing defective polypropylene resin that wasn’t approved by the FDA.… Read More


The FDA has issued a final order reclassifying transvaginal mesh used to repair Pelvic Organ Prolapse (POP) from class II (moderate-risk) to class III (high-risk). The FDA will also require manufacturers of every surgical mesh used to treat POP to conduct a PreMarket Approval application demonstrating the safety and effectiveness of their mesh product for treating POP. Manufacturers have 30 months — two and one half years — to show that their products are safe and effective for POP. These new FDA orders do not apply to mesh sold for Stress Urinary Incontinence (SUI) or abdominal repair.… Read More


An Indiana woman was awarded $12.5 million dollars against Johnson & Johnson’s Ethicon unit in damages for the injuries she suffered from their ProLift transvaginal mesh implant. The Court of Common Pleas jury awarded $5.5 million dollars in compensatory damages and added $7 million dollars in punitive damages to punish Johnson & Johnson for recklessly marketing the device.… Read More


Posted by Marilyn McGoldrick on Mar 6, 2015 9:58:22 AM Johnson & Johnson’s Ethicon unit has been ordered to pay $5.7 million dollars to a California woman who was damaged by a TVT-Abbrevo pelvic mesh sling device. Thousands of defective transvaginal mesh products have been implanted in women suffering from the medical conditions Pelvic Organ… Read More